Characterization, efficacy, pharmacokinetics, and biodistribution of 5 kDa mPEG modified tetrameric canine uricase variant
Authors:
- Kai FanKFKai Fan
- Hua LuoHLHua Luo
- Xuefeng MaXMXuefeng Ma
- Riyong LiuRLRiyong Liu
- Li YangLYLi Yang
- Chunlan HuCHChunlan Hu
- Zhenmin ChenZCZhenmin Chen
- Zhiqiang MinZMZhiqiang Min
- Dongzhi WeiDWDongzhi Wei
- 1 July 2012
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 430 (1-2) , 307-317
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- PegloticaseNature Reviews Drug Discovery, 2010
- Differing effects of exogenous and endogenous hydrogen sulphide in carrageenan‐induced knee joint synovitis in the ratBritish Journal of Pharmacology, 2010
- The Evolutionary Fate of the Genes Encoding the Purine Catabolic Enzymes in Hominoids, Birds, and ReptilesMolecular Biology and Evolution, 2010
- The role of aldosterone blockade in murine lupus nephritisArthritis Research & Therapy, 2008
- PEG-uricase in the management of treatment-resistant gout and hyperuricemiaAdvanced Drug Delivery Reviews, 2008
- Exclusion of Urate Oxidase as a Candidate Gene for Hyperuricosuria in the Dalmatian Dog Using an Interbreed BackcrossJournal of Heredity, 2005
- Management of Acute and Chronic Gouty ArthritisDrugs, 2004
- Tissue Distribution of 111In-Labeled Uricase Conjugated with Charged Dextrans and Polyethylene Glycol.Journal of Pharmacobio-Dynamics, 1991
- Site-directed mutagenesis by overlap extension using the polymerase chain reactionGene, 1989
- Urate Oxidase in Primate PhylogenesisEuropean Journal of Biochemistry, 1970